TITLE

Frecuencia de leucemias agudas

AUTHOR(S)
González-Salas, Wendy Marlene; Olarte-Carrillo, Irma; Gutiérrez-Romero, Mario; Montaño-Figueroa, Efreen Horacio; Martínez-Murillo, Carlos; Ramos-Peñafiel, Christian Omar
PUB. DATE
March 2012
SOURCE
Revista Medica del IMSS;2012, Vol. 50 Issue 2, p167
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: to compare the frequency of acute leukemia in two periods of study in a reference Hospital at Mexico City. Methods: it was an observational study. There were registered 250 cases with the morphology diagnostic criterion of acute leukemia. Results: 63 cases versus 92 of acute lymphoid leukemia (ALL) and 16 versus 79 acute myeloid leukemia (AML) of 1990-1992 versus 2008-2009 respectively was observed; corresponding to 62 % in total of ALL in both periods and 38 % of AML. The ALL was the most frequent variant (62 % versus 38 %). The median age was 26 years, male 52 %. It showed a significant increase in the number of admissions in the period of 2008-2009 and acute promyelocytic leukemia also showed an increase (p = 0.001). Conclusions: acute leukemia is the main cause of admission, mortality and morbidity. Our study differs slightly from the literature; the leukemia that diagnostic with major frequency was the acute lymphoid leukemia increasing his number in the period of 2008-2009. The significant rise due to an increase use of new diagnostic tools such as the flow cytometry and molecular biology.
ACCESSION #
82511508

 

Related Articles

  • Value of Multifaced Approach Diagnosis and Classification of Acute Leukemias. ANGELESCU, Silvana; BERBEC, Nicoleta Mariana; COLITA, Andrei; BARBU, Doina; LUPU, Anca Roxana // Maedica - a Journal of Clinical Medicine;2012, Vol. 7 Issue 3, p254 

    The article focuses on several processes of diagnosing and classifying acute leukemias (ALs). It states that the use cytochemistry approach to the morphologic assessment of AL could help differentiate acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). It says that...

  • Decoding Acute Leukemias with Flowcytometric Study. Bansal, Shivani; Sharma, Gaurav; Kishore, Kaushal; Gupta, Geeta // Indian Journal of Public Health Research & Development;Apr-Jun2016, Vol. 7 Issue 2, p31 

    Introduction:- Flowcytometric studies facilitate identification of leukemic cells, proper classification of acute leukemias and helps in institution of suitable treatment plans in various types of acute leukemias. Aim:- Correct diagnosis and classification of Acute Leukemias on the basis of...

  • Are cup-like blasts specific to AML patients with FLT3 ITD and a normal karyotype? An ALL case report and review of the literature. Mehtap, Özgür; Ateşoğlu, Elif Birtaş; Gönüllü, Emel; Keski, Hakan; Hacıhanefioğlu, Abdullah // Turkish Journal of Hematology;Jun2011, Vol. 28 Issue 2, p142 

    Cup-like morphology is defined as cup-like nuclear invagination spanning ≥25% of the nuclear diameter in >10% of blasts. Studies have shown that FLT3 ITD and normal cytology are strongly associated with cup-like morphology in acute myeloid leukemia (AML) patients. Herein we describe a...

  • Acute Leukemia.  // Current Medical Literature: Leukemia & Lymphoma;2006, Vol. 14 Issue 4, p96 

    The article presents abstracts of studies about acute leukemia. They include "Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia," "JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but...

  • Acute lymphoblastic leukemia with Burkitt-like morphologic features and high myeloperoxidase activity. Michael E Rytting; Hagop Kantarjian; Maher Albitar // American Journal of Clinical Pathology;Aug2009, Vol. 132 Issue 2, p182 

    Expression of a high level of myeloperoxidase (MPO) as a sole myeloid marker in acute leukemias that express typical lymphoblastic markers is unusual. Herein we report 5 cases of MPO+, otherwise typical acute lymphoblastic leukemia (ALL) without the expression of other myeloid markers. In most...

  • Flow Cytometric Immunophenotyping of Cerebrospinal Fluid Specimens. Craig, Fiona E.; Ohori, N. Paul; Gorrill, Timothy S.; Swerdlow, Steven H. // American Journal of Clinical Pathology;Jan2011, Vol. 135 Issue 1, p22 

    Flow cytometric immunophenotyping (FCI) is recommended in the evaluation of cerebrospinal fluid (CSF) specimens for hematologic neoplasms. This study reviewed FCI of CSF specimens collected for primary diagnosis (n = 77) and follow-up for known malignancy (n = 153). FCI was positive in 11 (4.8%)...

  • Prognostic significance of flow cytometry findings in Turkish adult acute leukemia patients. BASTURK, A.; AKINCI, S.; HACIBEKIROGLU, T.; GUNEY, T.; KUTLUCAN, A.; CERAN, F.; AKALIN, S. D.; OZTURK, S. M. B.; OKUTAN, H.; OZET, G.; DILEK, I. // European Review for Medical & Pharmacological Sciences;2015, Vol. 19 Issue 18, p3360 

    OBJECTIVE: Several factors are known to affect prognosis of acute leukemia such as age, high leukocyte count, cytogenetic abnormality, performance status and recurrent leukemia. We aimed to investigate the association between cell surface markers and prognostic determinants such as recurrence at...

  • FLOW CYTOMETRIC AND DEMOGRAPHIC ANALYSIS OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN HOSPITAL UNIVERSITI SAINS MALAYSIA. M. Y., Shafini; M. N., Noor Haslina; W. M., Wan Haslindawani; B., Rosnah; R., Marini // Malaysian Journal of Medical Sciences;Jan2007 Supplement, Vol. 14, p144 

    Introduction: Acute leukemia results from clonal proliferation of immature hematopoietic cells at an early stage of differentiation including primitive cells with multilineage potential. ALL is broadly classified as having T- or B-cell origin. This study was carried out to analyse the proportion...

  • The effect of the dual Src/Abl kinase inhibitor AZD0530 on Philadelphia positive leukaemia cell lines. Gwanmesia, Patricia Mambou; Romanski, Annette; Schwarz, Kerstin; Bacic, Biserka; Ruthardt, Martin; Ottmann, Oliver G. // BMC Cancer;2009, Vol. 9, Special section p1 

    Background: Imatinib mesylate, a selective inhibitor of Abl tyrosine kinase, is efficacious in treating chronic myeloid leukaemia (CML) and Ph+ acute lymphoblastic leukaemia (ALL). However, most advanced-phase CML and Ph+ ALL patients relapse on Imatinib therapy. Several mechanisms of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics